The rise in pancreatic cancer diagnoses can be attributed to detection of smaller, early-stage endocrine cancer, and not an increase in pancreatic adenocarcinoma, according to a study published Nov. 19 in the Annals of Internal Medicine.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
